Skip to main content
SpringerLink
Log in

Assessing Quality of Life in Patients with Acne Vulgaris

Implications for Treatment

  • Review Article
  • Published:
American Journal of Clinical Dermatology Aims and scope Submit manuscript

Abstract

Diagnosing acne is easy. However, treatment must be adapted to the type and severity of acne, and must also take into account the impact of acne on patients’ quality of life. As there is not always a correlation between the severity of acne and its impact on quality of life, it can be helpful for the dermatologist to use a quality of life scale to determine the psychological impact of acne on patients. Either global scales or specific scales for acne can be used. This article reviews the different scales used for evaluation of quality of life in patients with acne.

Consideration of specific scales suggests that the Acne Disability Index/Cardiff Acne Disability Index is the easiest scale to use in routine dermatology practice. The Acne Quality of Life scale is particularly useful for evaluating anxiety and depression. The Acne-Specific Quality of Life questionnaire has been mainly validated in adult acne. The Assessment of the Psychological and Social Effects of Acne scale has yet to be validated. Clinical trials indicate that use of global and specific scales together has complementary benefits.

In the management of acne, evaluation of quality of life may help to detect depression in teenagers. It may also help to enhance adherence to treatment, which is a crucial factor for success. Finally, there are now validated quality of life scales that are easy to use during patient consultations (taking <2 minutes to complete) by clinicians wishing to evaluate quality of life in patients with acne.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Table I

Similar content being viewed by others

Notes

  1. The use of trade names is for product identification purposes only and does not imply endorsement.

References

  1. Smithard A, Glazebrook C, Williams HC. Acne prevalence, knowledge about acne and psychological morbidity in mid-adolescence: a community-based study. Br J Dermatol 2001; 145: 274-9

    Article  PubMed  CAS  Google Scholar 

  2. Fried RG, Shalita AR. Acné et psychisme: interactions. Cutis et Psyché 1992; 2: 28-34

    Google Scholar 

  3. Toyoda M, Nakamura M, Morohashi M. Neuropeptides and sebaceous glands. Fur J Dermatol 2002; 12: 422-7

    CAS  Google Scholar 

  4. Toyoda M, Nakamura M, Makino T, et al. Sebaceous glands in acne patients express high levels of neutral endopeptidases. Exp Dermatol 2002; 11: 241-7

    Article  PubMed  CAS  Google Scholar 

  5. Green J, Sinclair RD. Perceptions of acne vulgaris in final year medical student written examination answers. Australas J Dermatol 2001; 42 (2): 98-101

    Article  PubMed  CAS  Google Scholar 

  6. The World Health Organization quality of life assessment (WHOQOL): position paper from the World Health Organization. Soc Sci Med 1995; 41: 1403-9

    Google Scholar 

  7. Cribier B. Acne and quality of life [in French]. Ann Dermatol Venereol 2000; 127 Suppl. 2: 2S13-4

  8. Chren MM, Lasek RJ, Quinn LM, et al. Skindex, a quality of life measure for patients with skin disease: reliability, validity, and responsiveness. J Invest Dermatol 1996; 107: 707-13

    Article  PubMed  CAS  Google Scholar 

  9. Lasek RJ, Chren MM. Acne vulgaris and the quality of life of adult dermatology patients. Arch Dermatol 1998; 134: 454-8

    Article  PubMed  CAS  Google Scholar 

  10. Hayashi N, Higaki Y, Kawamoto K, et al. A cross-sectional analysis of quality of life in Japanese acne patients using the Japanese version of Skindex-16. J Dermatol 2004; 31: 971-6

    PubMed  Google Scholar 

  11. Anderson RT, Rajagopalan R. Development and validation of a quality of life instrument for cutaneous diseases. J Am Acad Dermatol 1997; 37: 41-50

    Article  PubMed  CAS  Google Scholar 

  12. Anderson R, Rajagopalan R. Responsiveness of the Dermatology-Specific Quality of Life (DSQL) instrument to treatment for acne vulgaris in a placebo-controlled clinical trial. Qual Life Res 1998; 7: 723-34

    Article  PubMed  CAS  Google Scholar 

  13. Mosam A, Vawda NB, Gordhan AIL et al. Quality of life issues for South Africans with acne vulgaris. Clin Exp Dermatol 2005; 30: 6-9

    Article  PubMed  CAS  Google Scholar 

  14. Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI): a simple practical measure for routine clinical use. Clin Exp Dermatol 1994; 19: 210-6

    Article  PubMed  CAS  Google Scholar 

  15. Mallon E, Newton IN, Klassen A, et al. The quality of life in acne: a comparison with general medical conditions using generic questionnaires. Br J Dermatol 1999; 140: 672-6

    Article  PubMed  CAS  Google Scholar 

  16. Klassen AF, Newton IN, Mallon E. Measuring quality of life in people referred for specialist care of acne: comparing generic and disease-specific measures. J Am Acad Dermatol 2000; 43: 229-33

    Article  PubMed  CAS  Google Scholar 

  17. Boehncke WH, Ochsendorf F, Paeslack I, et al. Decorative cosmetics improve the quality of life in patients with disfiguring skin diseases. Fur J Dermatol 2002; 12: 577-80

    Google Scholar 

  18. Oakley AM. The Acne Disability Index: usefulness confirmed. Australas J Dermalot 1996; 37: 37-9

    Article  CAS  Google Scholar 

  19. Salek MS, Khan GK, Finlay AY. Questionnaire techniques in assessing acne handicap: reliability and validity study. Qual Life Res 1996; 5: 131-8

    Article  PubMed  CAS  Google Scholar 

  20. Dréno B, Finlay AY, Nocera T, et al. The Cardiff Acne Disability Index: cultural and linguistic validation in French. Dermatology 2004; 208: 104-8

    Article  PubMed  Google Scholar 

  21. Girman CJ, Hartmeier S, Thiboudot D, et al. Evaluating health-related quality of life in patients with facial acne: development of a self-administered questionnaire for clinical trials. Qual Life Res 1996; 5: 481-90

    Article  PubMed  CAS  Google Scholar 

  22. Martin AR, Lookingbill DP, Botek A. Health related quality of life among patients with facial acne: assessment of a new acne-specific questionnaire. Clin Exp Dermatol 2001; 26: 381-5

    Google Scholar 

  23. Fehnel SE, McLeod LD, Brandman J, et al. Responsiveness of the Acne-Specific Quality of Life questionnaire (Acne-QoL) to treatment for acne vulgaris in placebo-controlled clinical trials. Qual Life Res 2002; 11: 809-16

    Article  PubMed  CAS  Google Scholar 

  24. McLeod LD, Fehnel SE, Brandman J, et al. Evaluating minimal clinically important differences for the Acne-Specific Quality of Life questionnaire. Pharmacoeconomics 2003; 21: 1069-79

    Article  PubMed  Google Scholar 

  25. Gupta MA, Johnson MA, Gupta AK. The development of an Acne Quality of Life scale: reliability, validity, and relation to subjective acne severity in mild to moderate acne vulgaris. Acta Derm Venereol 1998; 78: 451-6

    Article  PubMed  CAS  Google Scholar 

  26. Yazici K, Baz K, Yazici AE, et al. Disease-specific quality of life is associated with anxiety and depression in patients with acne. J Fur Acad Dermatol Venereol 2004; 18: 435-9

    Article  CAS  Google Scholar 

  27. Weiss JW, Shavin J, Davis M. Preliminary results of a nonrandomized, multicenter, open-label study of patient satisfaction after treatment with combination benzoyl peroxide/clindamycin topical gel for mild to moderate acne. Clin Ther 2002; 24: 1706-17

    Article  PubMed  CAS  Google Scholar 

  28. Layton AM, Eady A, Cunliffe WJ. A reassessment of acne: what constitutes severe acne? Br J Dermatol 1991; 125 Suppl. 38: 35-6

    Google Scholar 

  29. Niemeier V, Kupfer J, Demmelbauer-Ebner M, et al. Coping with acne vulgaris: evaluation of the chronic skin disorder questionnaire in patients with acne. Dermatology 1998; 134: 454-8

    Article  Google Scholar 

  30. Lewis-Jones MS, Finlay AY. The Children’s Dermatology Life Quality Index (CDLQI): initial validation and practical use. Br J Dermatol 1995; 132: 942-9

    Article  PubMed  CAS  Google Scholar 

  31. Baldwin HE. The interaction between acne vulgaris and the psyche. Cutis 2002 Aug; 70 (2): 133-9

    PubMed  Google Scholar 

  32. Rapp DA, Brenes GA, Feldman SR, et al. Anger and acne: implications for quality of life, patient satisfaction and clinical care. Br J Dermatol 2004 Jul; 151 (1): 183-9

    Article  PubMed  CAS  Google Scholar 

  33. Tan JK. Psychosocial impact of acne vulgaris: evaluating the evidence. Skin Therapy Lett 2004; 9: 1-3

    PubMed  CAS  Google Scholar 

  34. Jaeschke R, Singer J, Guyatt G. Measurement of health status: ascertaining the minimal clinically important difference. Control Clin Trials 1989; 10: 407-15

    Article  PubMed  CAS  Google Scholar 

  35. Gollnick H, Cunliffe W, Berson D, et al. Management of acne: a report from a Global Alliance to Improve Outcomes in Acne. J Am Acad Dermatol 2003; 49 (1 Suppl.): S1-37

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

No sources of funding were used to assist in the preparation of this review. The author has no conflicts of interest that are directly relevant to the content of the review.

Author information

Authors and Affiliations

  1. Department of Dermatology, Hotel Dieu, Place Alexis Ricordeau, Nantes, 44093, Nantes Cedex 01, France

    Brigitte Dréno

Authors
  1. Brigitte Dréno
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Brigitte Dréno.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dréno, B. Assessing Quality of Life in Patients with Acne Vulgaris. Am J Clin Dermatol 7, 99–106 (2006). https://doi.org/10.2165/00128071-200607020-00003

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128071-200607020-00003

Keywords

Search

Navigation